Organigram Global (OGI) Income from Continuing Operations (2018 - 2026)
Organigram Global (OGI) reported Income from Continuing Operations of 23724707.19 for Q1 2026, down 19.82% year-over-year from 29588285.91 in Q1 2025, and down 0.53% quarter-over-quarter from 23850289.77 in Q4 2025.
Organigram Global (OGI) Income from Continuing Operations (2018 - 2026) Analysis & Trends
Organigram Global (OGI) has 7 years of Income from Continuing Operations data on file, last reported at 23724707.19 in Q1 2026.
- Income from Continuing Operations for Q1 2026 came in at 23724707.19, down 19.82% year-over-year; the trailing twelve-month figure through Mar 2026 was 90177420.25 (up 727.78% YoY), and the FY2025 annual result was 113227924.09, changed N/A from the prior year.
- Income from Continuing Operations slipped to 23724707.19 in Q1 2026 per OGI's latest filing, from 23850289.77 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 29588285.91 in Q1 2025 and troughed at 13014137.37 in Q4 2024.
- A 3-year average of 22544355.06 and a median of 23787498.48 in 2025 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2025 and 2026: Income from Continuing Operations soared 83.26% in 2025, then dropped 19.82% in 2026.
- A 3-year view of Income from Continuing Operations shows it stood at 13014137.37 in 2024, then soared by 83.26% to 23850289.77 in 2025, then declined by 0.53% to 23724707.19 in 2026.
- Business Quant data shows OGI's Income from Continuing Operations at 23724707.19 in Q1 2026, 23850289.77 in Q4 2025, and 29588285.91 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 370.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 21.05 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -66.53 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -92.12 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 118.42 Mn |
| 10 | Organigram Global | 731.20 Mn | 673.26 Mn | 11.96 Mn | 23.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.72 Mn |
| Dec 31, 2025 | 23.85 Mn |
| Mar 31, 2025 | 29.59 Mn |
| Dec 31, 2024 | 13.01 Mn |
| May 31, 2021 | 4.77 Mn |
| Feb 28, 2021 | -61.74 Mn |
| Nov 30, 2020 | -28.39 Mn |
| Aug 31, 2020 | -173.93 Mn |
| May 31, 2020 | -64.27 Mn |
| Feb 29, 2020 | -6.83 Mn |
| Nov 30, 2019 | 459,000.00 |
| Aug 31, 2019 | -16.98 Mn |
| May 31, 2019 | -7.60 Mn |
| Feb 28, 2019 | -6.39 Mn |
| Nov 30, 2018 | 29.52 Mn |